Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.555 USD | -0.96% | -12.71% | +128.32% |
01:50pm | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
09/05 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+128.32% | 3.94Cr | |
+4.15% | 11TCr | |
+11.50% | 11TCr | |
-13.01% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.19% | 1.7TCr | |
+3.10% | 1.37TCr | |
+37.30% | 1.24TCr |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Sensei Biotherapeutics : Piper Sandler Starts Sensei Biotherapeutics at Overweight With $25 Price Target